- Q1 2024 Pharming Group NV Earnings Call TranscriptMay 08, 2024€1.05Earnings
- Q4 2023 Pharming Group NV Earnings Call TranscriptMar 14, 2024€1.05Earnings
- Q3 2023 Pharming Group NV Earnings Call TranscriptOct 26, 2023€1.14Earnings
- Q2 2023 Pharming Group NV Earnings Call TranscriptAug 03, 2023€1.08Earnings
- Pharming Group NV Annual Shareholders Meeting TranscriptMay 17, 2023
- Q1 2023 Pharming Group NV Earnings Call TranscriptMay 11, 2023€1.13Earnings
- Pharming Group NV Corporate Analyst Meeting TranscriptMar 27, 2023
- Q4 2022 Pharming Group NV Earnings Call TranscriptMar 16, 2023€1.07Earnings
- Q3 2022 Pharming Group NV Earnings Call TranscriptOct 27, 2022€1.26Earnings
- Q2 2022 Pharming Group NV Earnings Call TranscriptAug 04, 2022€0.761Earnings
- Q1 2022 Pharming Group NV Earnings Call TranscriptMay 12, 2022€0.8535Earnings
- Q4 2021 Pharming Group NV Earnings Call TranscriptMar 24, 2022€0.891Earnings
- Q4 2021 Pharming Group NV Earnings Call TranscriptMar 17, 2022€0.891Earnings
- Pharming Group NV Announces Leniolisib Results Call TranscriptFeb 03, 2022
- Q3 2021 Pharming Group NV Earnings Call TranscriptOct 28, 2021€0.7854Earnings
- Q2 2021 Pharming Group NV Earnings Call TranscriptAug 05, 2021€1Earnings
- Pharming Group NV and Orchard Therapeutics PLC Announce Collaboration to Develop and Commercialize Ex Vivo Autologous HSC Gene Therapy for Hereditary Angioedema Call TranscriptJul 01, 2021
- Pharming Group NV Annual Shareholders Meeting TranscriptMay 19, 2021
- Q1 2021 Pharming Group NV Earnings Call TranscriptMay 13, 2021€1.08Earnings
- Q4 2020 Pharming Group NV Earnings Call TranscriptMar 04, 2021€1.12Earnings
Q4 2021 Pharming Group NV Earnings Call Transcript
Hello, and welcome to Pharming's Full Year 2021 Results Call. My name is Jordan, and I'll be coordinating your call today. (Operator Instructions)
I'm now going to hand over to Pharming's CEO, Sijmen de Vries, to begin. Sijmen, please go ahead.
Thank you very much, Jordan.
Good morning and good afternoon, ladies and gentlemen, and welcome to our full year results conference. I have here with me our CFO, Jeroen Wakkerman; and our Chief Medical Officer, Anurag Relan. We will be taking you through a short presentation. Of course, there's questions and answers afterwards. But before I do that, I would like you to take a look at the next slide with the forward-looking statements as we will be making some forward-looking statements that are based on our current beliefs and assumptions and expectations, and those can obviously, as you know, change.
So let's just move on to the next slide. And there, you see some pictures of us and maybe we can move on to Slide
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)